OPEN END TURBO OPTIONSSCHEIN - INMODE Stock

Certificat

DE000JQ3S9L6

Real-time Bid/Ask 05:07:54 2024-06-14 EDT
0.6 EUR / 0.63 EUR -2.38% Intraday chart for OPEN END TURBO OPTIONSSCHEIN - INMODE
Current month-7.35%
1 month+5.00%
Date Price Change
24-06-14 0.61 -3.17%
24-06-13 0.63 -5.97%
24-06-12 0.67 +4.69%
24-06-11 0.64 +3.23%
24-06-10 0.62 +1.64%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 04:44 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying INMODE LTD.
Issuer J.P. Morgan
WKN JQ3S9L
ISINDE000JQ3S9L6
Date issued 2022-07-22
Strike 12.06 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.91
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.21
Lowest since issue 0.52
Spread 0.03
Spread %4.76%

Company Profile

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Sector
-
More about the company

Ratings for InMode Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: InMode Ltd.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
18.2 USD
Average target price
25.6 USD
Spread / Average Target
+40.66%
Consensus